» Articles » PMID: 34798944

Assessing Patient-Reported Outcomes in Pediatric Rheumatic Diseases: Considerations and Future Directions

Overview
Publisher Elsevier
Specialty Rheumatology
Date 2021 Nov 20
PMID 34798944
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

For children with pediatric rheumatic diseases (PRDs), the inclusion of patient-reported outcomes (PROs) is critical to inform decision making in health care delivery and research settings. PROs are direct reports from a child on their health status, without interpretation by anyone else. PROs improve understanding of the patient experience, allow clinicians to provide patient-centered care, and add value to clinical trials. When PROs cannot be collected directly from the patient, caregiver-proxy reports can provide important information on the child's more observable symptoms and functioning. In this article, we describe the current use of PROs in specific PRDs, align current research with best practice recommendations for both clinical care and research settings, highlight exciting new developments, and identify areas for future research.

Citing Articles

Evaluating anchor variables and variation in meaningful score differences for PROMIS Pediatric measures in children and adolescents living with a rheumatic disease.

Zigler C, Li Z, Hernandez A, Randell R, Mann C, Weitzman E Qual Life Res. 2024; 33(12):3449-3457.

PMID: 39400691 PMC: 11599406. DOI: 10.1007/s11136-024-03800-2.

References
1.
Lunt L, Shoop-Worrall S, Smith N, Cleary G, McDonagh J, Smith A . Validation of novel patient-centred juvenile idiopathic arthritis-specific patient-reported outcome and experience measures (PROMs/PREMs). Pediatr Rheumatol Online J. 2020; 18(1):91. PMC: 7678156. DOI: 10.1186/s12969-020-00481-2. View

2.
Hinds P, Gilger E, Kline N, Burleson C, Bottomley S, Quargnenti A . Comparing patient, parent, and staff descriptions of fatigue in pediatric oncology patients. Cancer Nurs. 1999; 22(4):277-88; quiz 288-9. DOI: 10.1097/00002820-199908000-00004. View

3.
Morgan E, Riebschleger M, Horonjeff J, Consolaro A, Munro J, Thornhill S . Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016. J Rheumatol. 2017; 44(12):1884-1888. PMC: 5914507. DOI: 10.3899/jrheum.161389. View

4.
Moorthy L, Peterson M, Baratelli M, Harrison M, Onel K, Chalom E . Multicenter validation of a new quality of life measure in pediatric lupus. Arthritis Rheum. 2007; 57(7):1165-73. DOI: 10.1002/art.22988. View

5.
Irwin D, Gross H, Stucky B, Thissen D, Morgan DeWitt E, Lai J . Development of six PROMIS pediatrics proxy-report item banks. Health Qual Life Outcomes. 2012; 10:22. PMC: 3312870. DOI: 10.1186/1477-7525-10-22. View